References
1. Immune-mediated haemolytic anaemia. Day MJ, Mackin AJ. In Day MJ (ed): Clinical Immunology of the Dog and Cat, 2nd ed––London: Manson Publishing, 2011, pp 94-121.
2. Immune-mediated neutropenia suspected in five dogs. Perkins MC, Canfield P, Churcher RK, Malik R. Aust Vet J 82:52-57, 2004.
3. Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia. Kennedy LJ, Barnes A, Ollier WE, Day MJ. Tissue Antigens 68:502-508, 2006.
4. Detection of erythrocyte binding IgM and IgG by flow cytometry in sick dogs with Babesia canis canis or Babesia canis vogeli infection. Carli E, Tasca S, Trotta M, et al. Vet Parasitol 162:51-57, 2009.
5. Immune-mediated haemolytic anaemia in 110 dogs in Victoria, Australia. McAlees TJ. Aust Vet J 88:25-28, 2010.
6. Immune-mediated haemolytic anaemia. Day MJ. In Day MJ, Kohn B (eds): BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine, 2nd ed—Gloucester: BSAVA, 2012, pp 59-66.
7. Vaccine side effects: Fact and fiction. Day MJ. Vet Microbiol 117:51-58, 2006.
8. Erythrocyte-bound immunoglobulin isotypes in dogs with immune-mediated hemolytic anemia: 54 cases (2001-2010). Harkin KR, Hicks JA, Wilkerson MJ. JAVMA 241:227-232, 2012.
9. Anti-erythrocyte antibodies and disease associations in anemic and nonanemic dogs. Morley P, Mathes M, Guth A, Dow S. J Vet Intern Med 22:886-892, 2008.
10. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography. Fenty RK, Delaforcade AM, Shaw SP, O’Toole TE. JAVMA 238:463-467, 2011.
11. Performance of 2 microtiter canine Coombs’ tests. Overmann JA, Sharkey LC, Weiss DJ, Borjesson DL. Vet Clin Pathol 36:179-183, 2007.
12. Pattern of Coombs’ test reactivity has diagnostic significance in dogs with immune-mediated haemolytic anaemia. Warman SM, Murray JK, Ridyard A, et al. J Small Anim Prac 49:525-530, 2008.
13. Haemoplasma infection is not a common cause of canine immune-mediated haemolytic anaemia in the UK. Warman SM, Helps CR, Barker EN, et al. J Small Anim Pract 51:534-539, 2010.
14. Good agreement of conventional and gel-based direct agglutination test in immune-mediated haemolytic anaemia. Piek CJ, Teske E, van Leeuwen MW, Day MJ. Acta Vet Scand 54:10, 2012.
15. Coombs’ testing and its diagnostic significance in dogs and cats. Wardrop KJ. Vet Clin North Am Small Anim Pract 42:43-51, 2012.
16. Immunomodulatory drugs and their application to the management of canine immune-mediated disease. Whitley NT, Day MJ. J Small Anim Pract 52:70-85, 2011.
17. Immunomodulators, immunostimulants, and immunotherapies in small animal veterinary medicine. Thacker EL. Vet Clin North Am Small Anim Pract 40:473-483, 2010.
18. Choosing the right drug: Immunosuppressants. Whitley N. In Practice 34:322-329, 2012.
19. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: A randomized controlled clinical trial. Mason N, Duval D, Shofer FS, Giger U. J Vet Intern Med 17:206-212, 2003.
20. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs. Helmond SE, Polzin DJ, Armstrong PJ, et al.
J Vet Intern Med 24:597-605, 2010.
21. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). Weinkle TK, Center SA, Randolph JE, et al. JAVMA 226:1869-1880, 2005.
22. Idiopathic immune-mediated hemolytic anemia: Treatment, outcome and prognostic factors in 149 dogs. Piek CJ, Junius G, Dekker JA, et al. J Vet Intern Med 22:366-373, 2008.